Latest | F'cast | |
---|---|---|
Div Yield | 2.2% | 0.0% |
Div Cover | 6.1 | 5.3 |
Op Mrgn | 2.5% | 3.8% |
ROCE | 14.8% |
Latest | F'cast | |
---|---|---|
P/E | 7.3 | 7.4 |
PEG | 0.3 | 0.7 |
Pr/Revenue | 0.2 | 0.2 |
Pr/Book | 1.2 |
Latest | F'cast | |
---|---|---|
Revenue | -6.1% | -1.5% |
PBT | 18.1% | 27.6% |
EPS | 29.2% | -4.6% |
DPS | 100.0% | 10.2% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-20 | 978.40 | (96.10) | (36.70)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-21 | 1,135.20 | (13.30) | 9.60p | 5.6 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 1,421.40 | 32.80 | 9.90p | 4.0 | 1.3 | +3% | n/a | 0.0% |
31-Dec-23 | 1,332.00 | 30.90 | 11.30p | 5.6 | 0.4 | +14% | 1.20p | 1.9% |
31-Dec-24 | 1,251.10 | 36.50 | 14.60p | 7.3 | 0.3 | +29% | 2.40p | 2.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 1,231.84 | 46.57 | 13.93p | 7.7 | n/a | -5% | 2.65p | 0.0% |
31-Dec-26 | 1,269.98 | 50.81 | 14.95p | 7.2 | 1.0 | +7% | 3.05p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Costain awarded Urenco framework agreement | 20-Mar-2025 | 07:00 | RNS |
Costain FY 2024 | 11-Mar-2025 | 07:00 | RNS |
Investor Presentation via Investor Meet Company | 10-Feb-2025 | 12:00 | RNS |
Costain selected as delivery partner for Urenco ... | 20-Mar-2025 | ShareCast |
Costain doubles dividend as FY profit comes in a... | 11-Mar-2025 | ShareCast |
Berenberg starts Costain at 'buy' | 14-Feb-2025 | ShareCast |
Costain hungry for more takeovers | 22-Aug-2014 | Express & Star |
Costain's North Sea contract extended | 21-Aug-2014 | The Herald |
Mouchel board turns down Costain's bid approach | 23-Dec-2010 | The Independent |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 107.00p |
Change Today | -0.50p |
% Change | -0.47 % |
52 Week High | 111.50 |
52 Week Low | 75.00 |
Volume | 379,344 |
Shares Issued | 268.77m |
Market Cap | £287.58m |
RiskGrade | 234 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 5 |
Buy | 0 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 6 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 17-Apr-25 | 12-Sep-24 |
Paid | 29-May-25 | 18-Oct-24 |
Amount | 2.00p | 0.40p |
Time | Volume / Share Price |
16:19 | 16 @ 107.00p |
16:35 | 14,869 @ 107.00p |
16:35 | 115,575 @ 107.00p |
16:35 | 1 @ 107.00p |
16:35 | 1 @ 107.00p |
CEO | Alex Vaughan |
CFO | Helen Willis |
You are here: research